Clinical Trials in Saarbrücken, Germany
Locations / Saarbrücken, Germany
Delta Trials records 326 clinical trials conducted in Saarbrücken, Germany, making it a notable site of clinical research activity. These trials across 248 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 18 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Saarbrücken has changed over time.
326
Total Trials
248
Conditions
18
Terminated since 2020
Browse by condition (248 total)
- Breast cancer 20 trialsAll Breast cancer trials
- Diabetes mellitus, type 2 16 trialsAll Diabetes mellitus, type 2 trials
- Crohn's disease 11 trialsAll Crohn's disease trials
- Rheumatoid arthritis 9 trialsAll Rheumatoid arthritis trials
- Chronic lymphocytic leukemia 9 trialsAll Chronic lymphocytic leukemia trials
- Diabetes 8 trialsAll Diabetes trials
- All Pulmonary disease, chronic obstructive trials
- Breast neoplasms 7 trialsAll Breast neoplasms trials
- Acute myeloid leukemia 6 trialsAll Acute myeloid leukemia trials
- All Chronic obstructive pulmonary disease trials
- Pancreatic cancer 5 trialsAll Pancreatic cancer trials
- Lymphoma 5 trialsAll Lymphoma trials
- Type 2 diabetes mellitus 5 trialsAll Type 2 diabetes mellitus trials
- Acute myeloid leukemia (aml) 5 trialsAll Acute myeloid leukemia (aml) trials
- Ulcerative colitis 5 trialsAll Ulcerative colitis trials
- Leukemia 5 trialsAll Leukemia trials
- Ovarian cancer 5 trialsAll Ovarian cancer trials
- Multiple myeloma 5 trialsAll Multiple myeloma trials
- Anemia 4 trialsAll Anemia trials
- All Chronic obstructive pulmonary disease (COPD) trials